Showing results (1-10 of 304) with videos related to

Sort By:
Pageof 31
Medizinische Klinik (Munich, Germany : 1983)|August 19, 2007
[Novel indications for phosphodiesterase type 5 inhibitors]Stephan Rosenkranz, Evren Caglayan, Erland Erdmann
International Journal of Molecular Sciences|August 12, 2023
Differential Role of Aldosterone and Transforming Growth Factor Beta-1 in Cardiac RemodelingPiotr Kmieć, Stephan Rosenkranz, Margarete Odenthal, et al.
The Journal of Biological Chemistry|January 11, 2005
Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3'-kinase is importantMarius Vantler, Evren Caglayan, Wolfram H Zimmermann, et al.
AIDS (London, England)|April 20, 2004
Ritonavir exhibits anti-atherogenic properties on vascular smooth muscle cellsKai Kappert, Evren Caglayan, Anselm T Bäumer, et al.
FEBS Letters|December 5, 2006
PI3-kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Src family kinasesMarius Vantler, Michael Huntgeburth, Evren Caglayan, et al.
Expert Opinion on Investigational Drugs|November 15, 2011
Imatinib mesylate for the treatment of pulmonary arterial hypertensionHenrik ten Freyhaus, Daniel Dumitrescu, Eva Berghausen, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 25, 2010
Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational studyFikret Er, Orhan Aslan, Evren Caglayan, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 18, 2005
17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor levelKai Kappert, Evren Caglayan, Michael Huntgeburth, et al.
Archives of Internal Medicine|January 25, 2006
Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud diseaseEvren Caglayan, Michael Huntgeburth, Thomas Karasch, et al.
Cardiovascular Research|December 17, 2008
Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentationJan Sparwel, Marius Vantler, Evren Caglayan, et al.
Pageof 31